Articles

EHA Scientific Working Group meeting on ageing and haematology

BJH - volume 10, issue 3, may 2019

D. Bron MD, PhD, S. Wittnebel MD, PhD, V. Thibaud MD

After a successful first edition in Lisbon, a second edition of this scientific working group meeting was held in Warsaw in October 2018. The objective was to organise roundtables with scientists, clinicians, onconurses and patient’s organisations to improve the management of older patients with haematological disorders. Several unsolved issues were debated as outlined below.

(BELG J HEMATOL 2019;10(3):127–9)

Read more

PP03 Amsacrine combined with high dose cytarabine in relapsed/refractory acute myeloid leukemia (rraml)

BJH - 2018, issue Abstract Book BHS, february 2018

A. Salaroli , D. Bron MD, PhD, M. Paesmans , B. Cantinieaux , P. Heimann MD, PhD, P. Lewalle MD, PhD, S. Wittnebel MD, PhD

Read more

PP40 Anti-Pd1 inhibitor follow by Allo Stem cell transplantation in 3 heavily pretreated lymphoma’s patients: Experience from Institut Jules Bordet

BJH - 2018, issue Abstract Book BHS, february 2018

M. Maerevoet MD, P. Lewalle MD, PhD, N. Meuleman MD, PhD, C. Spilleboudt , A. Salaroli , S. Wittnebel MD, PhD

Read more

P18 Early discontinuation of lenalidomide in patients with relapsing or refractory multiple myeloma: predictive factors for stopping in the real life

BJH - volume 8, issue Abstract Book BHS, february 2017

A. Pistone , M. Maerevoet MD, S. Wittnebel MD, PhD, M. Vercruyssen , S. Buntinx , C. Spilleboudt , D. Bron MD, PhD, N. Meuleman MD, PhD

Read more

Belgium recommendations for the management of acute promyelocytic leukaemia

BJH - volume 7, issue 6, december 2016

S. Wittnebel MD, PhD

Summary

The management of acute promyelocytic leukaemia has evolved considerably. The standard front-line approach with all-trans retinoic acid and chemotherapy has recently been challenged by the chemo-free combination of all-trans retinoic acid and arsenic trioxide, which has emerged as the new standard of care for non-high-risk disease. This review gives an update of the management of acute promyelocytic leukaemia.

(BELG J HEMATOL 2016;7(6):224–8)

Read more

Highlights of the EHA

BJH - volume 6, issue 4, october 2015

D. Bron MD, PhD, S. Wittnebel MD, PhD

11 – 14 June 2015, Vienna, Austria
 

summary

2015 was an important year for the EHA, celebrating its 20th anniversary, presenting ‘innovation in haematology’ as the theme of the year and welcoming almost 10.000 participants. Innovations were observed in many different diseases and selected major breakthroughs are summarised below.

(BELG J HEMATOL 2015;6(4): 169–72)

Read more

P2.08 Short delay of occurrence of myelodysplasia after Peptide Receptor Radionuclide Therapy (PRRT) in neuroendocrine tumors (NETs)

BJH - volume 6, issue Abstract Book BHS, january 2015

G. Claes , J. Nguyen , N. Charette , G. Machiels , M. Vercruyssen , S. Wittnebel MD, PhD, N. Meuleman MD, PhD, D. Bron MD, PhD

Read more